FLAC Logo

Frazier Lifesciences Acquisition Corporation (FLAC) Stock Forecast & Price Prediction

Live FLAC Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | |

$20.14

-0.05 (-0.25%)

12 Month Price Forecast For FLAC

$20.14
Current Price
$301.75M
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to FLAC Price Forecasts

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

FLAC Price Momentum

-9.8%
1 Week Change
-21.2%
1 Month Change
+1.7%
1 Year Change
-22.4%
Year-to-Date Change
-26.2%
From 52W High of $27.29
+32.6%
From 52W Low of $15.19

๐Ÿค” Considering Frazier Lifesciences (FLAC)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 8, 2025 3:18 AM UTC

FLAC Analyst Ratings & Price Targets

Currently, there are no Wall Street analyst price targets or forecasts available for FLAC (Frazier Lifesciences).

FLAC is currently trading at $20.14. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

FLAC Analyst Consensus

0
Buy
0
Hold
0
Sell

FLAC Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $20.14

Latest FLAC Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for FLAC.

Date Firm Analyst Rating Change Price Target

Stocks Similar to Frazier Lifesciences Acquisition Corporation

The following stocks are similar to Frazier Lifesciences based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Frazier Lifesciences Acquisition Corporation (FLAC) Financial Data

Frazier Lifesciences Acquisition Corporation has a market capitalization of $301.75M with a P/E ratio of 65.8x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.

Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of +3.2%.

Valuation Metrics

Market Cap $301.75M
Enterprise Value $0
P/E Ratio 65.8x
PEG Ratio 0.0x
Price/Sales 0.0x

Growth & Margins

Revenue Growth (YoY) N/A
Gross Margin N/A
Operating Margin N/A
Net Margin N/A
EPS Growth N/A

Financial Health

Cash/Price Ratio +0.1%
Current Ratio 0.5x
Debt/Equity 0.0x
ROE +3.2%
ROA +3.0%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Frazier Lifesciences Acquisition Corporation logo

Frazier Lifesciences Acquisition Corporation (FLAC) Company Overview

About Frazier Lifesciences Acquisition Corporation

What They Do

Business Model

Additional Information

Company Information

Sector

Industry

Employees

0

CEO

Country

United States

IPO Year

2021

Frazier Lifesciences Acquisition Corporation (FLAC) Latest News & Analysis

FLAC stock latest news image
Quick Summary

On November 22, 2022, Frazier Lifesciences Acquisition Corporation completed a business combination and raised approximately $235 million in an oversubscribed PIPE led by Frazier Healthcare and Bain Capital.

Why It Matters

The completion of the business combination and a substantial PIPE indicates strong confidence from major investors, potentially boosting the companyโ€™s market position and investor interest.

Source: GlobeNewsWire
Market Sentiment: Neutral
FLAC stock latest news image
Quick Summary

Frazier Lifesciences Acquisition Corp (FLAC) shareholders approved its merger with NewAmsterdam Pharma, a firm developing oral therapies for cardiometabolic diseases.

Why It Matters

Approval of the business combination signals potential growth for FLAC and NewAmsterdam, attracting investor interest in the cardiometabolic therapy sector and impacting stock valuations.

Source: Business Wire
Market Sentiment: Neutral

Frequently Asked Questions About FLAC Stock

What is Frazier Lifesciences Acquisition Corporation's (FLAC) stock forecast for 2025?

Analyst forecasts for Frazier Lifesciences Acquisition Corporation (FLAC) are not currently available. The stock is trading at $20.14.

Is FLAC stock a good investment in 2025?

Analyst ratings for FLAC are not currently available. The stock is currently trading at $20.14. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for FLAC stock?

Price predictions from Wall Street analysts for FLAC are not currently available. The stock is trading at $20.14.

What is Frazier Lifesciences Acquisition Corporation's business model?

N/A

What is the highest forecasted price for FLAC Frazier Lifesciences Acquisition Corporation?

Price targets from Wall Street analysts for FLAC are not currently available. The stock is trading at $20.14.

What is the lowest forecasted price for FLAC Frazier Lifesciences Acquisition Corporation?

Price targets from Wall Street analysts for FLAC are not currently available. The stock is trading at $20.14.

What is the overall FLAC consensus from analysts for Frazier Lifesciences Acquisition Corporation?

Analyst ratings for FLAC are not currently available. The stock is trading at $20.14.

How accurate are FLAC stock price projections?

Stock price projections, including those for Frazier Lifesciences Acquisition Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.